SecSonar.com

DBV Technologies S.A. (DBVT)

DBV Technologies S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

DBV Technologies S.A. (DBVT) is a Biotechnology company based in FR with a market capitalization of $454.8M. Free cash flow was negative at -$121.7M. This page tracks DBVT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

FR · 106 employees · IPO Oct 22, 2014

Valuation

Valuation & price

$18.32 · as of May 26, 2026 · -25.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.69

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$24.54$16.52$8.51Jul 25Dec 25Jul 26Jul 7, 25$11.01Jul 9, 25$11.00Jul 11, 25$10.80Jul 15, 25$10.16Jul 17, 25$9.71Jul 21, 25$9.50Jul 23, 25$9.47Jul 25, 25$9.46Jul 29, 25$9.80Jul 31, 25$8.51Aug 4, 25$8.81Aug 6, 25$9.87Aug 11, 25$9.75Aug 13, 25$9.80Aug 15, 25$9.99Aug 19, 25$9.77Aug 21, 25$9.54Aug 25, 25$9.79Aug 27, 25$9.49Aug 29, 25$9.65Sep 3, 25$9.11Sep 5, 25$8.97Sep 9, 25$9.40Sep 11, 25$9.95Sep 16, 25$9.84Sep 18, 25$9.59Sep 22, 25$9.50Sep 24, 25$9.36Sep 26, 25$9.16Sep 30, 25$10.00Oct 2, 25$12.25Oct 6, 25$13.29Oct 8, 25$15.88Oct 10, 25$15.00Oct 14, 25$15.65Oct 16, 25$17.00Oct 21, 25$15.97Oct 23, 25$14.86Oct 27, 25$15.99Oct 29, 25$15.21Oct 31, 25$14.64Nov 4, 25$14.36Nov 6, 25$14.04Nov 10, 25$13.58Nov 12, 25$13.77Nov 14, 25$13.24Nov 18, 25$13.93Nov 20, 25$13.77Nov 25, 25$12.96Nov 28, 25$13.09Dec 2, 25$12.90Dec 4, 25$13.05Dec 8, 25$16.98Dec 10, 25$20.00Dec 12, 25$18.37Dec 16, 25$17.98Dec 18, 25$21.52Dec 22, 25$20.27Dec 24, 25$19.03Dec 29, 25$19.52Jan 2, 26$19.05Jan 6, 26$16.63Jan 8, 26$17.00Jan 12, 26$17.93Jan 14, 26$17.34Jan 16, 26$20.78Jan 21, 26$21.67Jan 23, 26$24.54Jan 27, 26$24.44Jan 29, 26$22.96Feb 2, 26$21.59Feb 4, 26$23.41Feb 9, 26$22.22Feb 11, 26$22.60Feb 13, 26$20.90Feb 18, 26$20.55Feb 20, 26$21.46Feb 24, 26$22.27Feb 26, 26$21.52Mar 2, 26$23.25Mar 4, 26$22.79Mar 6, 26$21.87Mar 10, 26$23.54Mar 12, 26$20.06Mar 17, 26$19.84Mar 19, 26$19.45Mar 23, 26$20.19Mar 25, 26$20.27Mar 27, 26$20.00Mar 31, 26$20.89Apr 2, 26$21.06Apr 7, 26$20.45Apr 9, 26$21.40Apr 13, 26$22.14Apr 15, 26$21.25Apr 17, 26$21.34Apr 22, 26$19.64Apr 24, 26$19.80Apr 28, 26$20.80Apr 30, 26$21.00May 4, 26$19.47May 6, 26$20.10May 8, 26$19.73May 12, 26$20.00May 14, 26$19.84May 18, 26$18.75May 20, 26$18.54May 22, 26$18.18May 28, 26$18.99Jun 1, 26$18.80Jun 3, 26$17.70Jun 5, 26$16.59Jun 9, 26$16.03Jun 11, 26$16.54Jun 15, 26$18.12Jun 17, 26$16.28Jun 22, 26$15.70Jun 24, 26$15.60Jun 26, 26$16.01Jul 2, 26$15.82
$8.5152-week range$24.54
Loading valuation history…

Fundamentals

Key fundamentals

$454.8M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$121.7M

Free cash flow (USD)

-$172.5M

Net debt

Net cash position

-10.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.9MFY 2017$11.5MFY 2018$12.8MFY 2019$14.7MFY 2020$11.3MFY 2021$5.7MFY 2022$4.8MFY 2023$15.7MFY 2024$0.00FY 2025$0.00
$7.9M$0

Free cash flow by year

2016 → 2025

FY 2016$-74.7MFY 2017$-171.5MFY 2018$-193.2MFY 2019$-153.9MFY 2020$-168.4MFY 2021$-109.2MFY 2022$-56.5MFY 2023$-80.3MFY 2024$-106.8MFY 2025$-121.7M
-$74.7M-$121.7M

Gross margin by year

2021 → 2023

FY 2021-62.5%FY 2022-322.9%FY 2023100.0%
-62.5%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-K/A filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBLA Submission UpdateJun 29, 2026Filing
  • 8-K eventPerformance Share Unit PlanJun 5, 2026Filing
  • 8-K eventBylaw Amendments and Shareholder MeetingJun 3, 2026Filing
  • 8-K eventPerformance Share Unit PlanMay 5, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing

Questions

Frequently asked questions

What is DBV Technologies S.A.'s market cap?

DBV Technologies S.A. (DBVT) has a market capitalization of $454.8M.

What is DBVT's P/E ratio?

A meaningful P/E ratio is not available for DBVT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is DBVT's price-to-book (P/B) ratio?

DBVT trades at 2.69 times book value per share.

Are insiders buying DBVT stock?

SEC Form 4 filings show no open-market insider buys at DBV Technologies S.A. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ASMB

Assembly Biosciences, Inc.

$441.9M

NGNE

Neurogene Inc.

$441.4M

OCGN

Ocugen, Inc.

$470M

PRTC

PureTech Health plc

$439.4M

ADCT

ADC Therapeutics S.A.

$433.1M

EBS

Emergent BioSolutions Inc.

$478.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.